Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T C Jarvis

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
RNA (New York, N.Y.)|May 1, 1996
Inhibition of vascular smooth muscle cell proliferation by ribozymes that cleave c-myb mRNAT C Jarvis, L J Alby, A A Beaudry, et al.
Journal of Medicinal Chemistry|April 1, 1988
Highly selective kappa opioid analgesics. Synthesis and structure-activity relationships of novel N-[(2-aminocyclohexyl)aryl]acetamide and N-[(2-aminocyclohexyl)aryloxy]acetamide derivativesC R Clark, P R Halfpenny, R G Hill, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 23, 1996
Nuclease-resistant ribozymes decrease stromelysin mRNA levels in rabbit synovium following exogenous delivery to the knee jointC M Flory, P A Pavco, T C Jarvis, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 22, 2000
Ribozymes as tools for therapeutic target validation in arthritisT C Jarvis, K S Bouhana, M E Lesch, et al.
The Journal of Biological Chemistry|November 15, 1996
Optimizing the cell efficacy of synthetic ribozymes. Site selection and chemical modifications of ribozymes targeting the proto-oncogene c-mybT C Jarvis, F E Wincott, L J Alby, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
RNA (New York, N.Y.)|May 1, 1996
Inhibition of vascular smooth muscle cell proliferation by ribozymes that cleave c-myb mRNAT C Jarvis, L J Alby, A A Beaudry, et al.
Journal of Medicinal Chemistry|April 1, 1988
Highly selective kappa opioid analgesics. Synthesis and structure-activity relationships of novel N-[(2-aminocyclohexyl)aryl]acetamide and N-[(2-aminocyclohexyl)aryloxy]acetamide derivativesC R Clark, P R Halfpenny, R G Hill, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 23, 1996
Nuclease-resistant ribozymes decrease stromelysin mRNA levels in rabbit synovium following exogenous delivery to the knee jointC M Flory, P A Pavco, T C Jarvis, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 22, 2000
Ribozymes as tools for therapeutic target validation in arthritisT C Jarvis, K S Bouhana, M E Lesch, et al.
The Journal of Biological Chemistry|November 15, 1996
Optimizing the cell efficacy of synthetic ribozymes. Site selection and chemical modifications of ribozymes targeting the proto-oncogene c-mybT C Jarvis, F E Wincott, L J Alby, et al.
Pageof 2